he Malignant Hyperthermia Association of the United
States (MHAUS) is pleased to announce the availability
of an award in the amount $1,500 to the author of
a manuscript related to malignant hyperthermia (MH)."
MH is an inherited disorder of muscle, which is
“triggered” by commonly used anesthetic
agents and may lead to death or disability. Early
diagnosis and prompt treatment are the key to reducing
morbidity and mortality related to MH. MH may occur
at any time during an anesthetic, whether in a hospital,
ambulatory surgery center or an office-based setting.
A large variety of programs have been developed
by the scientific panel at MHAUS in order to increase
awareness of the syndrome and its manifestations,
including procedure manuals for recognizing and
treating MH applicable to the hospital or to the
ambulatory surgery center, a continuing medical
education-accredited slide show and a variety of
publications.
In order to promote awareness of MH and its various
manifestations and to encourage continued study
of the syndrome, Mr. George Massik, a founding member
of MHAUS, has graciously offered to support a writers’
award. The Daniel Massik Fund at the Foundation
for Jewish Philanthropies in Buffalo, New York,
was established by Mr. Massik in memory of his son
who died from MH. This award will provide a stipend
of $1,500 to an anesthesiology resident/fellow or
an anesthesiologist who is within five years of
ending his/her training to attend the ASA Annual
Meeting or, in special circumstances, another meeting
of similar merit.
Award Details
• The award will be given to the primary
author of the best manuscript concerning MH. The
format may be a case report, literature review
or original study.
• The document should address a significant
issue related to the problem of MH.
• Those participating must currently be
a resident/fellow in anesthesiology or an
anesthesiologist who is within five years of completing
his/her training.
• The paper must be a minimum of three double-spaced
typed pages and a maximum of 10 pages. The author’s
curriculum vitae should be included.
• The paper must not be in any stage of
publication.
• Deadline for receipt of the manuscript
in the MHAUS office is August 1, 2007.
The award will be presented at the annual MHAUS
Recognition Reception at the ASA Annual Meeting
in San Francisco in October 2007.
The winner will be notified by August 31, 2007,
to allow for coordination of travel plans.
For further information regarding the application
process for this award, please contact the Malignant
Hyperthermia Association of the United States (MHAUS),
attention Gloria Artist, via regular mail at P.O.
Box 1069, Sherburne, NY 13460; fax at (607) 674-7910;
or e-mail at gloria@mhaus.org.
|